Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00006175 · ClinicalTrials.gov registry record

Cyclooxygenase Levels Following Surgery to Remove Third Molars (Wisdom Teeth)

A clinical trial, sponsored by National Institute of Dental and Craniofacial Research (NIDCR).

Completed
Registry status
160
Enrollment target

NCT00006175 is a clinical trial that has completed, run by National Institute of Dental and Craniofacial Research (NIDCR). The registered enrollment target is 160 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00006175 has completed, sponsored by National Institute of Dental and Craniofacial Research (NIDCR).

COMPLETED
Registry status
160 participants
Enrollment target

Study Summary

This study will measure levels of an enzyme called cyclooxygenase in gum tissue following third molar (wisdom tooth) extraction. Cyclooxygenase is thought to contribute to pain that normally follows tissue injury or surgery. Healthy volunteers between 16 and 35 years of age who require removal of their third molars may be eligible for this study. Participants will receive an injection of a local anesthetic (lidocaine) in the mouth and a sedative (midazolam) through an arm vein before surgery. Before the tooth is removed, a small tissue sample (biopsy) will be collected from the gum tissue covering one of the lower third molars to be extracted. After surgery, a second biopsy will be taken at some point between just after surgery to the time when pain from the extraction starts to develop. These tissue samples will be analyzed for cyclooxygenase levels. Patients will stay in the clinic for up to 4 hours after surgery while the anesthetic wears off. During this time, they will complete pain questionnaires. If needed, patients may receive additional medicine for pain relief at any time during the surgery or the 4-hour observation period. They will also be given standard pain medication to take home at the end of the study.

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2000-08
Est. Completion 2005-10

What the Registry Record Tells You About NCT00006175

The ClinicalTrials.gov registry entry for NCT00006175 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Dental and Craniofacial Research (NIDCR), which has 91 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00006175 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00006175 about?

NCT00006175 is a clinical study titled "Cyclooxygenase Levels Following Surgery to Remove Third Molars (Wisdom Teeth)". This study will measure levels of an enzyme called cyclooxygenase in gum tissue following third molar (wisdom tooth) extraction. Cyclooxygenase is thought to contribute to pain that normally follows tissue injury or surgery. Healthy volunteers between 16 and 35 years of age who require removal of t...

What is the current status of trial NCT00006175?

This trial is currently completed. The enrollment target is 160 participants. The study started on 2000-08. Estimated completion is 2005-10.

Who is sponsoring clinical trial NCT00006175?

This trial is sponsored by National Institute of Dental and Craniofacial Research (NIDCR), which has 91 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.